SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-062137
Filing Date
2021-05-06
Accepted
2021-05-06 09:57:03
Documents
18
Period of Report
2021-05-06
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2115193d1_8k.htm   iXBRL 8-K 27987
2 EXHIBIT 23.1 tm2115193d1_ex23-1.htm EX-23.1 4558
3 EXHIBIT 99.1 tm2115193d1_ex99-1.htm EX-99.1 230333
4 EXHIBIT 99.2 tm2115193d1_ex99-2.htm EX-99.2 47841
8 GRAPHIC tm2115193d1_ex99-1img001.jpg GRAPHIC 1854
9 GRAPHIC tm2115193d1_ex99-1img002.jpg GRAPHIC 5004
10 GRAPHIC tm2115193d1_ex99-1img003.jpg GRAPHIC 3178
  Complete submission text file 0001104659-21-062137.txt   534290

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA cmrx-20210506.xsd EX-101.SCH 3187
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE cmrx-20210506_lab.xml EX-101.LAB 34592
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cmrx-20210506_pre.xml EX-101.PRE 22711
11 EXTRACTED XBRL INSTANCE DOCUMENT tm2115193d1_8k_htm.xml XML 3606
Mailing Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713
Business Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713 919.806.1074
CHIMERIX INC (Filer) CIK: 0001117480 (see all company filings)

IRS No.: 330903395 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35867 | Film No.: 21896220
SIC: 2834 Pharmaceutical Preparations